Kane Biotech Inc. (KNBIF) .
本頁證實的標準:
SharesGrow 綜合評分： 51/100 其中 2/7 項標準通過。
| Year | EPS（稀釋） | 營收 | 淨利潤 | 淨利潤率 |
|---|---|---|---|---|
| 2015 | $-0.08 | $104.62K | $-1.71M | -1634.4% |
| 2016 | $-0.07 | $244.76K | $-2.55M | -1041.3% |
| 2017 | $-0.05 | $1.04M | $-2.79M | -269.1% |
| 2018 | $-0.04 | $506.27K | $-3.26M | -644.1% |
| 2019 | $-0.01 | $1.69M | $-960.18K | -56.7% |
| 2020 | $-0.03 | $1.34M | $-3.72M | -277% |
| 2021 | $-0.04 | $1.61M | $-4.6M | -286.4% |
| 2022 | $-0.03 | $2.67M | $-3.89M | -145.8% |
| 2023 | $-0.04 | $148.98K | $-5.03M | -3379% |
| 2024 | $-0.02 | $2.08M | $6.1M | 293% |
